Dr. Surbhi Sidana specializes in the treatment of plasma cell disorders, such as multiple myeloma, amyloidosis and related disorders. Her research focuses on the development of novel therapeutic approaches, biomarkers and management of treatment toxicity in this field. Dr. Sidana's expertise includes blood and marrow transplantation and CAR-T cell therapy.

Home Department: Neurobiology
Faculty Advisor: Andrew Huberman
Talk Title: Barriers and solutions to retinal ganglion cell regeneration
Event: XXIII Biennial Meeting of the International Society for Eye Research
Supported by The Matthew Frank Family

Dr. Kanwaljeet Sunny Anand is a translational clinical researcher who pioneered research on the endocrine-metabolic stress responses of infants undergoing surgery and developed the first-ever scientific rationale for pain perception in early life. This provided a framework for newer methods of pain assessment, numerous clinical trials of analgesia/anesthesia in newborns, infants and older children.